56 related articles for article (PubMed ID: 6633511)
1. In vitro translational activity of messenger RNA following treatment of human colon carcinoma cells with sangivamycin.
Glazer RI; Hartman KD
Mol Pharmacol; 1983 Nov; 24(3):509-12. PubMed ID: 6633511
[TBL] [Abstract][Full Text] [Related]
2. In vitro translation of messenger RNA following exposure of human colon carcinoma cells in culture to 5-fluorouracil and 5-fluorouridine.
Glazer RI; Hartman KD
Mol Pharmacol; 1983 Mar; 23(2):540-6. PubMed ID: 6835205
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the cellular and RNA-dependent effects of sangivamycin and toyocamycin in human colon carcinoma cells.
Cohen MB; Glazer RI
Mol Pharmacol; 1985 Mar; 27(3):349-55. PubMed ID: 2579317
[TBL] [Abstract][Full Text] [Related]
4. Cytokinetic and biochemical effects of sangivamycin in human colon carcinoma cells in culture.
Glazer RI; Hartman KD
Mol Pharmacol; 1981 Nov; 20(3):657-61. PubMed ID: 7329408
[No Abstract] [Full Text] [Related]
5. Kinetic effects of sangivamycin in sarcoma 180 in vitro.
Ritch PS; Glazer RI; Cunningham RE; Shackney SE
Cancer Res; 1981 May; 41(5):1784-8. PubMed ID: 7214345
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and the inhibition of ribosomal RNA processing in human colon carcinoma cells.
Cohen MB; Glazer RI
Mol Pharmacol; 1985 Feb; 27(2):308-13. PubMed ID: 2578606
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
8. Effect of sangivamycin and xylosyladenine on the synthesis and methylation of polysomal ribonucleic acid in Ehrlich ascites cells in vitro.
Glazer RI; Hartman KD; Cohen OJ
Biochem Pharmacol; 1981 Oct; 30(19):2697-701. PubMed ID: 7295353
[No Abstract] [Full Text] [Related]
9. [Ability of translation factors from infected encephalomyocarditis viruses of ascites carcinoma cells to maintain the protein-synthetizing activity of cellular polyribosomes].
Kalinina NO; Skarlat IV
Biokhimiia; 1984 Apr; 49(4):629-32. PubMed ID: 6329325
[TBL] [Abstract][Full Text] [Related]
10. 9-Deazaadenosine. Cytocidal activity and effects on nucleic acids and protein synthesis in human colon carcinoma cells in culture.
Glazer RI; Hartman KD; Knode MC
Mol Pharmacol; 1983 Sep; 24(2):309-15. PubMed ID: 6888372
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of 18S ribosomal RNA of different origin on a wheat embryo cell-free translation system].
Karavanov AA; Shifter K; Khil'ko SN; Makarovskaia EE
Mol Biol (Mosk); 1980; 14(2):323-9. PubMed ID: 7383029
[TBL] [Abstract][Full Text] [Related]
12. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
Jiang W; Tillekeratne MP; Brattain MG; Banerji SS
Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753
[TBL] [Abstract][Full Text] [Related]
13. Regulation of p53 expression in response to 5-fluorouracil in human cancer RKO cells.
Ju J; Schmitz JC; Song B; Kudo K; Chu E
Clin Cancer Res; 2007 Jul; 13(14):4245-51. PubMed ID: 17634554
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of histone H1 phosphorylation by sangivamycin and other pyrrolopyrimidine analogues.
Saffer JD; Glazer RI
Mol Pharmacol; 1981 Jul; 20(1):211-7. PubMed ID: 7290086
[No Abstract] [Full Text] [Related]
15. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
Glazer RI; Lloyd LS
Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the inhibitory activities of sangivamycin and thiosangivamycin on nuclear ribonucleic acid synthesis in L1210 cells in vitro.
Glazer RI; Peale AL
Biochem Pharmacol; 1980 Feb; 29(3):305-10. PubMed ID: 7362643
[No Abstract] [Full Text] [Related]
17. Shape changes and chemokinesis of Walker carcinosarcoma cells: effects of protein kinase inhibitors (HA-1004, polymyxin B, sangivamycin and tamoxifen) and an inhibitor of diacylglycerol kinase (R 59022).
Zimmermann A; Keller H
Anticancer Res; 1993; 13(2):347-54. PubMed ID: 8390801
[TBL] [Abstract][Full Text] [Related]
18. In vitro translation of messenger RNA in a rabbit reticulocyte lysate cell-free system.
Olliver L; Boyd CD
Methods Mol Biol; 1996; 58():477-84. PubMed ID: 8713897
[No Abstract] [Full Text] [Related]
19. Expression of an estrogen receptor alpha variant protein in cell lines and tumors.
Fasco MJ; Keyomarsi K; Arcaro KF; Gierthy JF
Mol Cell Endocrinol; 2000 Aug; 166(2):156-69. PubMed ID: 11203301
[TBL] [Abstract][Full Text] [Related]
20. In vitro translation of messenger RNA in a rabbit reticulocyte lysate cell-free system.
Olliver L; Boyd CD
Methods Mol Biol; 1998; 86():221-7. PubMed ID: 9664473
[No Abstract] [Full Text] [Related]
[Next] [New Search]
